[Potential of lignin application in development of new antitumor drugs].
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D061945:Caspase Inhibitors; D004789:Enzyme Activation / Q000187:drug effects; D006801:Humans; D006861:Hydrogen Peroxide / Q000378:metabolism; D007328:Insulin / Q000235:genetics; D008031:Lignin / Q000494:pharmacology*; D019001:Nitric Oxide Synthase / Q000378:metabolism; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D019098:Telomerase / Q000378:metabolism; D014158:Transcription, Genetic / Q000187:drug effects
D000970:Antineoplastic Agents; D061945:Caspase Inhibitors; D007328:Insulin; D008031:Lignin; D006861:Hydrogen Peroxide; D019001:Nitric Oxide Synthase; D051057:Proto-Oncogene Proteins c-akt; D019098:Telomerase